HVTN 702 was a clinical trial which the HIV Vaccine Trials Network organized to develop an HIV vaccine. In February 2020 the organizers halted the trial after finding no evidence of efficacy. [1] [2] [3]
Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV. [4] [5]
In 2016 various media outlets announced the start of the research. [6] [7] [8]
HVTN 702 was based on outcomes of the RV 144 trial. [9]
HVTN 702 was a clinical trial which the HIV Vaccine Trials Network organized to develop an HIV vaccine. In February 2020 the organizers halted the trial after finding no evidence of efficacy. [1] [2] [3]
Around December 2019 various media outlets reported that HVTN 702 could be an effective vaccine in preventing HIV. [4] [5]
In 2016 various media outlets announced the start of the research. [6] [7] [8]
HVTN 702 was based on outcomes of the RV 144 trial. [9]